These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4740236)

  • 21. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 22. [Continuous intra-arterial infusions in obliterating diseases of the lower limbs].
    Chudakov MI; Vorotyntsev SF
    Khirurgiia (Mosk); 1974 May; (5):87-90. PubMed ID: 4457694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries].
    Hubl S; Wesolowski J
    Pol Tyg Lek; 1973 Jul; 28(30):1150-1. PubMed ID: 4732712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Muscular blood flow during inhibition of 3', 5'-AMP-phosphodiesterase. Clinical and experimental studies using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Köhler M
    Arzneimittelforschung; 1973 Apr; 23(4):566-70. PubMed ID: 4351130
    [No Abstract]   [Full Text] [Related]  

  • 26. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
    Buckert D; Harwart D
    Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mode of action of pentoxifyllin].
    Müller R; Lehrach F; Grigoleit HG
    Med Monatsschr; 1975 Nov; 29(11):487-91. PubMed ID: 1196239
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Nolte D
    Arzneimittelforschung; 1971 Oct; 21(10):1453-6. PubMed ID: 5171859
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man].
    Christ O; Gleixner K; Kellner HM; Müller R; Rupp W
    Arzneimittelforschung; 1972 Nov; 22(11):1933-7. PubMed ID: 4679068
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with the vasotherapeutic agent Trental in dermatology].
    Bossong W
    Z Haut Geschlechtskr; 1972 Aug; 47(16):711-24. PubMed ID: 4652483
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of peripheral circulation disorders with 1-benzyl-1-(3-dimethyl-amino-propoxy)-cycloheptane].
    Denck H
    Wien Med Wochenschr; 1973 Mar; 123(11):174-8. PubMed ID: 4692075
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chelates in the treatment of obliterating arterial diseases. (Preliminary report)].
    Brücknerová O; Tulácek J; Krojzl O
    Vnitr Lek; 1968 Sep; 14(9):841-5. PubMed ID: 4971419
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problem of vasodilatation in the therapy of arterial diseases].
    Pratesi F; Caramelli L; Corsi C; Spinelli P; Tesi M
    Minerva Cardioangiol; 1973 Mar; 21(3):197-211. PubMed ID: 4708941
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].
    Hess H; Franke I; Jauch M
    Fortschr Med; 1973 Jun; 91(17):743-8. PubMed ID: 4577522
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 38. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of thymoxamine in peripheral arterial pathology].
    Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
    Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
    [No Abstract]   [Full Text] [Related]  

  • 40. [Toxicity of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine in animal experiment].
    Schultes E; Popendiker K; Doerr BI; Leuschner F
    Arzneimittelforschung; 1971 Oct; 21(10):1446-53. PubMed ID: 5171858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.